摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6,8-ditert-butyl-2-oxochromen-3-yl)benzamide | 899089-16-8

中文名称
——
中文别名
——
英文名称
N-(6,8-ditert-butyl-2-oxochromen-3-yl)benzamide
英文别名
——
N-(6,8-ditert-butyl-2-oxochromen-3-yl)benzamide化学式
CAS
899089-16-8
化学式
C24H27NO3
mdl
——
分子量
377.483
InChiKey
UDJISVUAJAZSLU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.3
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    马尿酸3,5-二叔丁基水杨醛sodium acetate乙酸酐 作用下, 以60%的产率得到N-(6,8-ditert-butyl-2-oxochromen-3-yl)benzamide
    参考文献:
    名称:
    Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines
    摘要:
    A series of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines were synthesized and evaluated for their anti-hyperglycemic activity. Compounds 3g and 6d exhibited lowering of postprandial plasma glucose by 30.7%, 23.3% in SLM and 25.6%, 25.4% in STZ models respectively which is significant compared to metformin and glybenclamide. Other compounds exhibited moderate to good activity ranging from 19.5% to 32.8% in SLM and 3.26% to 25.4% in STZ models. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.03.003
点击查看最新优质反应信息

文献信息

  • Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines
    作者:Atma P. Dwivedi、Shailesh Kumar、Vandana Varshney、Amar B. Singh、Arvind K. Srivastava、Devi P. Sahu
    DOI:10.1016/j.bmcl.2008.03.003
    日期:2008.4
    A series of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines were synthesized and evaluated for their anti-hyperglycemic activity. Compounds 3g and 6d exhibited lowering of postprandial plasma glucose by 30.7%, 23.3% in SLM and 25.6%, 25.4% in STZ models respectively which is significant compared to metformin and glybenclamide. Other compounds exhibited moderate to good activity ranging from 19.5% to 32.8% in SLM and 3.26% to 25.4% in STZ models. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多